PHK
VINC

Point72 Hong Kong’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Point72 Hong Kong’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-35
Closed -$1K – 2501
2022
Q2 		$1K Buy
+35
New +$1.56K ﹤0.01% 1833
2022
Q1 		– Sell
-12
Closed -$2K – 2428
2021
Q4 		$2K Buy
+12
New +$2.99K ﹤0.01% 1785

Other funds holding VINC

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Point72 Hong Kong's VINC Position: Q3 2022 in Review

Point72 Hong Kong sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q3 2022, closing a stake of 35 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in VINC in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q4 2021. 42 funds tracked by Wall St. Rank hold VINC as of Q3 2022.

  • Point72 Hong Kong reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 35 Vincerx Pharma, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in Vincerx Pharma, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Point72 Hong Kong's Vincerx Pharma, Inc. Common Stock position peaked at $2K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.